Adrenal adrenaline- and noradrenaline-containing cells and celiac sympathetic ganglia are differentially controlled by centrally administered corticotropin-releasing factor and arginine–vasopressin in rats
The adrenal glands and sympathetic celiac ganglia are innervated mainly by the greater splanchnic nerves, which contain preganglionic sympathetic nerves that originated from the thoracic spinal cord. The adrenal medulla has two separate populations of chromaffin cells, adrenaline-containing cells (A...
Gespeichert in:
| Veröffentlicht in: | European journal of pharmacology 2007-06, Vol.564 (1-3), p.94-102 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 102 |
|---|---|
| container_issue | 1-3 |
| container_start_page | 94 |
| container_title | European journal of pharmacology |
| container_volume | 564 |
| creator | Yamaguchi-Shima, Naoko Okada, Shoshiro Shimizu, Takahiro Usui, Daisuke Nakamura, Kumiko Lu, Lianyi Yokotani, Kunihiko |
| description | The adrenal glands and sympathetic celiac ganglia are innervated mainly by the greater splanchnic nerves, which contain preganglionic sympathetic nerves that originated from the thoracic spinal cord. The adrenal medulla has two separate populations of chromaffin cells, adrenaline-containing cells (A-cells) and noradrenaline-containing cells (NA-cells), which have been shown to be differentially innervated by separate groups of the preganglionic sympathetic neurons. The present study was designed to characterize the centrally activating mechanisms of the adrenal A-cells, NA-cells and celiac sympathetic ganglia with expression of cFos (a marker for neural excitation), in regard to the brain prostanoids, in anesthetized rats. Intracerebroventricularly (i.c.v.) administered corticotropin-releasing factor (CRF) induced cFos expression in the adrenal A-cells, but not NA-cells, and celiac ganglia. On the other hand, i.c.v. administered arginine–vasopressin (AVP) resulted in cFos induction in both A-cells and NA-cells in the adrenal medulla, but not in the celiac ganglia. Intracerebroventricular pretreatment with indomethacin (an inhibitor of cyclooxygenase) abolished the CRF- and AVP-induced cFos expression in all regions described above. On the other hand, intracerebroventricular pretreatment with furegrelate (an inhibitor of thromboxane A2 synthase) abolished the CRF-induced cFos expression in the adrenal A-cells, but not in the celiac ganglia, and also abolished the AVP-induced cFos expression in both A-cells and NA-cells in the adrenal medulla. These results suggest that centrally administered CRF activates adrenal A-cells and celiac sympathetic ganglia by brain thromboxane A2-mediated and other prostanoid than thromboxane A2 (probably prostaglandin E2)-mediated mechanisms, respectively. On the other hand, centrally administered AVP activates adrenal A-cells and NA-cells by brain thromboxane A2-mediated mechanisms in rats. |
| doi_str_mv | 10.1016/j.ejphar.2007.02.021 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70505102</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014299907001884</els_id><sourcerecordid>70505102</sourcerecordid><originalsourceid>FETCH-LOGICAL-c546t-e09b1bf4e1b3dee0c99594251312192d0409c50cf989000536b8164244ff03023</originalsourceid><addsrcrecordid>eNp9kc-KFDEQxhtR3HH1DURy0VuPlfTfXIRlcVdhwYueQ3W6ejZDOmmTnoW57Tv4YL6DT2J6emA9CQWVfPzqq6Iqy95y2HLg9cf9lvbTPYatAGi2IFLwZ9mGt43MoeHiebYB4GUupJQX2asY9wBQSVG9zC54U1RQ82qT_b7qAzm0DNdsHOUMXc-cD_9I2rsZjTNuxzRZG09IehnULB7HCed7mo1mO3S7JDIMxHozDJQcZoPWHtliEby11LMu_ZIeTjr2YzKOc0KTpQ_JxidwMi4PZAnj0nRAPftw6ophtwxCfx5_PWD0U6CYEJYi4BxfZy8GtJHenPNl9uPm8_frL_ndt9uv11d3ua7Kes4JZMe7oSTeFT0RaCkrWYqKF1xwKXooQeoK9CBbuaytqLuW16Uoy2GAAkRxmX1Yfafgfx4ozmo0cVkNOvKHqBqooOInsFxBHXyMgQY1BTNiOCoOajmk2qv1kGo5pAKRgqeyd2f_QzdS_1R0vlwC3p8BjBrtENBpE5-4tinboi4S92nlKG3jwVBQURtymnoTSM-q9-b_k_wFCSzEmw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70505102</pqid></control><display><type>article</type><title>Adrenal adrenaline- and noradrenaline-containing cells and celiac sympathetic ganglia are differentially controlled by centrally administered corticotropin-releasing factor and arginine–vasopressin in rats</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Yamaguchi-Shima, Naoko ; Okada, Shoshiro ; Shimizu, Takahiro ; Usui, Daisuke ; Nakamura, Kumiko ; Lu, Lianyi ; Yokotani, Kunihiko</creator><creatorcontrib>Yamaguchi-Shima, Naoko ; Okada, Shoshiro ; Shimizu, Takahiro ; Usui, Daisuke ; Nakamura, Kumiko ; Lu, Lianyi ; Yokotani, Kunihiko</creatorcontrib><description>The adrenal glands and sympathetic celiac ganglia are innervated mainly by the greater splanchnic nerves, which contain preganglionic sympathetic nerves that originated from the thoracic spinal cord. The adrenal medulla has two separate populations of chromaffin cells, adrenaline-containing cells (A-cells) and noradrenaline-containing cells (NA-cells), which have been shown to be differentially innervated by separate groups of the preganglionic sympathetic neurons. The present study was designed to characterize the centrally activating mechanisms of the adrenal A-cells, NA-cells and celiac sympathetic ganglia with expression of cFos (a marker for neural excitation), in regard to the brain prostanoids, in anesthetized rats. Intracerebroventricularly (i.c.v.) administered corticotropin-releasing factor (CRF) induced cFos expression in the adrenal A-cells, but not NA-cells, and celiac ganglia. On the other hand, i.c.v. administered arginine–vasopressin (AVP) resulted in cFos induction in both A-cells and NA-cells in the adrenal medulla, but not in the celiac ganglia. Intracerebroventricular pretreatment with indomethacin (an inhibitor of cyclooxygenase) abolished the CRF- and AVP-induced cFos expression in all regions described above. On the other hand, intracerebroventricular pretreatment with furegrelate (an inhibitor of thromboxane A2 synthase) abolished the CRF-induced cFos expression in the adrenal A-cells, but not in the celiac ganglia, and also abolished the AVP-induced cFos expression in both A-cells and NA-cells in the adrenal medulla. These results suggest that centrally administered CRF activates adrenal A-cells and celiac sympathetic ganglia by brain thromboxane A2-mediated and other prostanoid than thromboxane A2 (probably prostaglandin E2)-mediated mechanisms, respectively. On the other hand, centrally administered AVP activates adrenal A-cells and NA-cells by brain thromboxane A2-mediated mechanisms in rats.</description><identifier>ISSN: 0014-2999</identifier><identifier>EISSN: 1879-0712</identifier><identifier>DOI: 10.1016/j.ejphar.2007.02.021</identifier><identifier>PMID: 17350615</identifier><identifier>CODEN: EJPHAZ</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Adrenal Medulla - drug effects ; Adrenal Medulla - innervation ; Adrenal Medulla - metabolism ; Animals ; Arachidonic Acid - metabolism ; Arachidonic Acid - physiology ; Arginine Vasopressin - pharmacology ; Benzofurans - pharmacology ; Biological and medical sciences ; Brain - cytology ; Brain - metabolism ; Brain arachidonic acid cascade ; Brain thromboxane A2 ; Central sympatho-adrenomedullary outflow ; cFos expression ; Corticotropin-Releasing Hormone - pharmacology ; Epinephrine - metabolism ; Ganglia, Sympathetic - drug effects ; Ganglia, Sympathetic - metabolism ; Gene Expression ; Genes, fos - drug effects ; Indomethacin - pharmacology ; Injections, Intraventricular ; Male ; Medical sciences ; Norepinephrine - metabolism ; Pharmacology. Drug treatments ; Photomicrography ; Prostaglandins - metabolism ; Prostaglandins - physiology ; Rats ; Rats, Wistar ; Thromboxane A2 - metabolism ; Thromboxane A2 - physiology</subject><ispartof>European journal of pharmacology, 2007-06, Vol.564 (1-3), p.94-102</ispartof><rights>2007 Elsevier B.V.</rights><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c546t-e09b1bf4e1b3dee0c99594251312192d0409c50cf989000536b8164244ff03023</citedby><cites>FETCH-LOGICAL-c546t-e09b1bf4e1b3dee0c99594251312192d0409c50cf989000536b8164244ff03023</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejphar.2007.02.021$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18748363$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17350615$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamaguchi-Shima, Naoko</creatorcontrib><creatorcontrib>Okada, Shoshiro</creatorcontrib><creatorcontrib>Shimizu, Takahiro</creatorcontrib><creatorcontrib>Usui, Daisuke</creatorcontrib><creatorcontrib>Nakamura, Kumiko</creatorcontrib><creatorcontrib>Lu, Lianyi</creatorcontrib><creatorcontrib>Yokotani, Kunihiko</creatorcontrib><title>Adrenal adrenaline- and noradrenaline-containing cells and celiac sympathetic ganglia are differentially controlled by centrally administered corticotropin-releasing factor and arginine–vasopressin in rats</title><title>European journal of pharmacology</title><addtitle>Eur J Pharmacol</addtitle><description>The adrenal glands and sympathetic celiac ganglia are innervated mainly by the greater splanchnic nerves, which contain preganglionic sympathetic nerves that originated from the thoracic spinal cord. The adrenal medulla has two separate populations of chromaffin cells, adrenaline-containing cells (A-cells) and noradrenaline-containing cells (NA-cells), which have been shown to be differentially innervated by separate groups of the preganglionic sympathetic neurons. The present study was designed to characterize the centrally activating mechanisms of the adrenal A-cells, NA-cells and celiac sympathetic ganglia with expression of cFos (a marker for neural excitation), in regard to the brain prostanoids, in anesthetized rats. Intracerebroventricularly (i.c.v.) administered corticotropin-releasing factor (CRF) induced cFos expression in the adrenal A-cells, but not NA-cells, and celiac ganglia. On the other hand, i.c.v. administered arginine–vasopressin (AVP) resulted in cFos induction in both A-cells and NA-cells in the adrenal medulla, but not in the celiac ganglia. Intracerebroventricular pretreatment with indomethacin (an inhibitor of cyclooxygenase) abolished the CRF- and AVP-induced cFos expression in all regions described above. On the other hand, intracerebroventricular pretreatment with furegrelate (an inhibitor of thromboxane A2 synthase) abolished the CRF-induced cFos expression in the adrenal A-cells, but not in the celiac ganglia, and also abolished the AVP-induced cFos expression in both A-cells and NA-cells in the adrenal medulla. These results suggest that centrally administered CRF activates adrenal A-cells and celiac sympathetic ganglia by brain thromboxane A2-mediated and other prostanoid than thromboxane A2 (probably prostaglandin E2)-mediated mechanisms, respectively. On the other hand, centrally administered AVP activates adrenal A-cells and NA-cells by brain thromboxane A2-mediated mechanisms in rats.</description><subject>Adrenal Medulla - drug effects</subject><subject>Adrenal Medulla - innervation</subject><subject>Adrenal Medulla - metabolism</subject><subject>Animals</subject><subject>Arachidonic Acid - metabolism</subject><subject>Arachidonic Acid - physiology</subject><subject>Arginine Vasopressin - pharmacology</subject><subject>Benzofurans - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Brain - cytology</subject><subject>Brain - metabolism</subject><subject>Brain arachidonic acid cascade</subject><subject>Brain thromboxane A2</subject><subject>Central sympatho-adrenomedullary outflow</subject><subject>cFos expression</subject><subject>Corticotropin-Releasing Hormone - pharmacology</subject><subject>Epinephrine - metabolism</subject><subject>Ganglia, Sympathetic - drug effects</subject><subject>Ganglia, Sympathetic - metabolism</subject><subject>Gene Expression</subject><subject>Genes, fos - drug effects</subject><subject>Indomethacin - pharmacology</subject><subject>Injections, Intraventricular</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Norepinephrine - metabolism</subject><subject>Pharmacology. Drug treatments</subject><subject>Photomicrography</subject><subject>Prostaglandins - metabolism</subject><subject>Prostaglandins - physiology</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Thromboxane A2 - metabolism</subject><subject>Thromboxane A2 - physiology</subject><issn>0014-2999</issn><issn>1879-0712</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc-KFDEQxhtR3HH1DURy0VuPlfTfXIRlcVdhwYueQ3W6ejZDOmmTnoW57Tv4YL6DT2J6emA9CQWVfPzqq6Iqy95y2HLg9cf9lvbTPYatAGi2IFLwZ9mGt43MoeHiebYB4GUupJQX2asY9wBQSVG9zC54U1RQ82qT_b7qAzm0DNdsHOUMXc-cD_9I2rsZjTNuxzRZG09IehnULB7HCed7mo1mO3S7JDIMxHozDJQcZoPWHtliEby11LMu_ZIeTjr2YzKOc0KTpQ_JxidwMi4PZAnj0nRAPftw6ophtwxCfx5_PWD0U6CYEJYi4BxfZy8GtJHenPNl9uPm8_frL_ndt9uv11d3ua7Kes4JZMe7oSTeFT0RaCkrWYqKF1xwKXooQeoK9CBbuaytqLuW16Uoy2GAAkRxmX1Yfafgfx4ozmo0cVkNOvKHqBqooOInsFxBHXyMgQY1BTNiOCoOajmk2qv1kGo5pAKRgqeyd2f_QzdS_1R0vlwC3p8BjBrtENBpE5-4tinboi4S92nlKG3jwVBQURtymnoTSM-q9-b_k_wFCSzEmw</recordid><startdate>20070614</startdate><enddate>20070614</enddate><creator>Yamaguchi-Shima, Naoko</creator><creator>Okada, Shoshiro</creator><creator>Shimizu, Takahiro</creator><creator>Usui, Daisuke</creator><creator>Nakamura, Kumiko</creator><creator>Lu, Lianyi</creator><creator>Yokotani, Kunihiko</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20070614</creationdate><title>Adrenal adrenaline- and noradrenaline-containing cells and celiac sympathetic ganglia are differentially controlled by centrally administered corticotropin-releasing factor and arginine–vasopressin in rats</title><author>Yamaguchi-Shima, Naoko ; Okada, Shoshiro ; Shimizu, Takahiro ; Usui, Daisuke ; Nakamura, Kumiko ; Lu, Lianyi ; Yokotani, Kunihiko</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c546t-e09b1bf4e1b3dee0c99594251312192d0409c50cf989000536b8164244ff03023</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adrenal Medulla - drug effects</topic><topic>Adrenal Medulla - innervation</topic><topic>Adrenal Medulla - metabolism</topic><topic>Animals</topic><topic>Arachidonic Acid - metabolism</topic><topic>Arachidonic Acid - physiology</topic><topic>Arginine Vasopressin - pharmacology</topic><topic>Benzofurans - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Brain - cytology</topic><topic>Brain - metabolism</topic><topic>Brain arachidonic acid cascade</topic><topic>Brain thromboxane A2</topic><topic>Central sympatho-adrenomedullary outflow</topic><topic>cFos expression</topic><topic>Corticotropin-Releasing Hormone - pharmacology</topic><topic>Epinephrine - metabolism</topic><topic>Ganglia, Sympathetic - drug effects</topic><topic>Ganglia, Sympathetic - metabolism</topic><topic>Gene Expression</topic><topic>Genes, fos - drug effects</topic><topic>Indomethacin - pharmacology</topic><topic>Injections, Intraventricular</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Norepinephrine - metabolism</topic><topic>Pharmacology. Drug treatments</topic><topic>Photomicrography</topic><topic>Prostaglandins - metabolism</topic><topic>Prostaglandins - physiology</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Thromboxane A2 - metabolism</topic><topic>Thromboxane A2 - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamaguchi-Shima, Naoko</creatorcontrib><creatorcontrib>Okada, Shoshiro</creatorcontrib><creatorcontrib>Shimizu, Takahiro</creatorcontrib><creatorcontrib>Usui, Daisuke</creatorcontrib><creatorcontrib>Nakamura, Kumiko</creatorcontrib><creatorcontrib>Lu, Lianyi</creatorcontrib><creatorcontrib>Yokotani, Kunihiko</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamaguchi-Shima, Naoko</au><au>Okada, Shoshiro</au><au>Shimizu, Takahiro</au><au>Usui, Daisuke</au><au>Nakamura, Kumiko</au><au>Lu, Lianyi</au><au>Yokotani, Kunihiko</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adrenal adrenaline- and noradrenaline-containing cells and celiac sympathetic ganglia are differentially controlled by centrally administered corticotropin-releasing factor and arginine–vasopressin in rats</atitle><jtitle>European journal of pharmacology</jtitle><addtitle>Eur J Pharmacol</addtitle><date>2007-06-14</date><risdate>2007</risdate><volume>564</volume><issue>1-3</issue><spage>94</spage><epage>102</epage><pages>94-102</pages><issn>0014-2999</issn><eissn>1879-0712</eissn><coden>EJPHAZ</coden><abstract>The adrenal glands and sympathetic celiac ganglia are innervated mainly by the greater splanchnic nerves, which contain preganglionic sympathetic nerves that originated from the thoracic spinal cord. The adrenal medulla has two separate populations of chromaffin cells, adrenaline-containing cells (A-cells) and noradrenaline-containing cells (NA-cells), which have been shown to be differentially innervated by separate groups of the preganglionic sympathetic neurons. The present study was designed to characterize the centrally activating mechanisms of the adrenal A-cells, NA-cells and celiac sympathetic ganglia with expression of cFos (a marker for neural excitation), in regard to the brain prostanoids, in anesthetized rats. Intracerebroventricularly (i.c.v.) administered corticotropin-releasing factor (CRF) induced cFos expression in the adrenal A-cells, but not NA-cells, and celiac ganglia. On the other hand, i.c.v. administered arginine–vasopressin (AVP) resulted in cFos induction in both A-cells and NA-cells in the adrenal medulla, but not in the celiac ganglia. Intracerebroventricular pretreatment with indomethacin (an inhibitor of cyclooxygenase) abolished the CRF- and AVP-induced cFos expression in all regions described above. On the other hand, intracerebroventricular pretreatment with furegrelate (an inhibitor of thromboxane A2 synthase) abolished the CRF-induced cFos expression in the adrenal A-cells, but not in the celiac ganglia, and also abolished the AVP-induced cFos expression in both A-cells and NA-cells in the adrenal medulla. These results suggest that centrally administered CRF activates adrenal A-cells and celiac sympathetic ganglia by brain thromboxane A2-mediated and other prostanoid than thromboxane A2 (probably prostaglandin E2)-mediated mechanisms, respectively. On the other hand, centrally administered AVP activates adrenal A-cells and NA-cells by brain thromboxane A2-mediated mechanisms in rats.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>17350615</pmid><doi>10.1016/j.ejphar.2007.02.021</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0014-2999 |
| ispartof | European journal of pharmacology, 2007-06, Vol.564 (1-3), p.94-102 |
| issn | 0014-2999 1879-0712 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_70505102 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Adrenal Medulla - drug effects Adrenal Medulla - innervation Adrenal Medulla - metabolism Animals Arachidonic Acid - metabolism Arachidonic Acid - physiology Arginine Vasopressin - pharmacology Benzofurans - pharmacology Biological and medical sciences Brain - cytology Brain - metabolism Brain arachidonic acid cascade Brain thromboxane A2 Central sympatho-adrenomedullary outflow cFos expression Corticotropin-Releasing Hormone - pharmacology Epinephrine - metabolism Ganglia, Sympathetic - drug effects Ganglia, Sympathetic - metabolism Gene Expression Genes, fos - drug effects Indomethacin - pharmacology Injections, Intraventricular Male Medical sciences Norepinephrine - metabolism Pharmacology. Drug treatments Photomicrography Prostaglandins - metabolism Prostaglandins - physiology Rats Rats, Wistar Thromboxane A2 - metabolism Thromboxane A2 - physiology |
| title | Adrenal adrenaline- and noradrenaline-containing cells and celiac sympathetic ganglia are differentially controlled by centrally administered corticotropin-releasing factor and arginine–vasopressin in rats |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T16%3A42%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adrenal%20adrenaline-%20and%20noradrenaline-containing%20cells%20and%20celiac%20sympathetic%20ganglia%20are%20differentially%20controlled%20by%20centrally%20administered%20corticotropin-releasing%20factor%20and%20arginine%E2%80%93vasopressin%20in%20rats&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=Yamaguchi-Shima,%20Naoko&rft.date=2007-06-14&rft.volume=564&rft.issue=1-3&rft.spage=94&rft.epage=102&rft.pages=94-102&rft.issn=0014-2999&rft.eissn=1879-0712&rft.coden=EJPHAZ&rft_id=info:doi/10.1016/j.ejphar.2007.02.021&rft_dat=%3Cproquest_cross%3E70505102%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70505102&rft_id=info:pmid/17350615&rft_els_id=S0014299907001884&rfr_iscdi=true |